Enzalutamide is a second-generation androgen receptor (AR) inhibitor with a triple mechanism of action: it competitively binds to the ligand-binding domain of AR, inhibits nuclear translocation of the activated receptor, and blocks its interaction with DNA, thereby suppressing the transcription of genes that promote tumor cell growth.
Usually ships within 24 hours.